US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

TCRX TScan Therapeutics Inc

8.01

0.00 (0.00%)

Pre Mercado

Última actualización: 06:05:37

Retrasado por 15 minutos

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

TScan Therapeutics (NASDAQ:TCRX)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas TScan Therapeutics.

TScan Therapeutics (NASDAQ:TCRX)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas TScan Therapeutics.

Noticias sobre TScan Therapeutics Inc TCRX

TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors
Jueves 9 de Mayo 2024 (2 horas hace) • GlobeNewswire Inc.

TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
Miércoles 24 de Abril 2024 (2 semanas hace) • GlobeNewswire Inc.

TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
Miércoles 24 de Abril 2024 (2 semanas hace) • GlobeNewswire Inc.

TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Lunes 22 de Abril 2024 (2 semanas hace) • GlobeNewswire Inc.

TScan Therapeutics Announces Closing of Upsized Public Offering
Viernes 19 de Abril 2024 (3 semanas hace) • GlobeNewswire Inc.

TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
Martes 16 de Abril 2024 (3 semanas hace) • GlobeNewswire Inc.

TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
Martes 16 de Abril 2024 (3 semanas hace) • GlobeNewswire Inc.

TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
Martes 16 de Abril 2024 (3 semanas hace) • GlobeNewswire Inc.

TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer
Lunes 8 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Martes 2 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Miércoles 6 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Miércoles 6 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Más de TScan Therapeutics Inc Artículos de Noticias

Verizon Communications

Health Care Select Sector

JP Morgan Chase

American Express

Energy Select Sector SPDR

Gold vs US Dollar

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones